HTAC Recommendation on Bivalent COVID-19 Vaccines as booster

[ANNOUNCEMENT] HTA PHILIPPINES ANNOUNCES THAT THE 2023 CALL FOR TOPIC NOMINATIONS WILL START ON OCTOBER 2023

[ANNOUNCEMENT] HTA COUNCIL RELEASES ITS PRELIMINARY RECOMMENDATION ON THE FINANCING OF 34 MEDICAL DEVICES TO BE INCLUDED IN Q1 UPDATE OF THE PEMDL

[ANNOUNCEMENT] HTA COUNCIL RELEASES ITS PRELIMINARY RECOMMENDATION ON THE FINANCING OF DOACS FOR NONVALVULAR ATRIAL FIBRILLATION

[ANNOUNCEMENT] HTA COUNCIL RELEASES ITS PRELIMINARY RECOMMENDATION ON THE NON-FINANCING OF CEREBROLYSIN FOR POST ISCHEMIC STROKE

HTA Philippines Guidance: Efforts to Facilitate the HTA Transfer

HTAC GUIDANCE: PNF INCLUSION OF RECOMBINANT HUMAN ERYTHROPOIETIN (EPOETIN ALFA) 4000 IU/ML SOLUTION FOR INJECTION (IV/SC) 1ML PRE-FILLED SYRINGE

HTAC GUIDANCE: PNF INCLUSION OF FILGRASTIM 300 MCG/0.9 ML SOLUTION (IV, SC), 0.9 ML PRE-FILLED SYRINGE

[ANNOUNCEMENT] CEREMONIAL TURNOVER OF HTA IMPLEMENTATION FROM THE DEPARTMENT OF HEALTH TO THE DEPARTMENT OF SCIENCE AND TECHNOLOGY

[ANNOUNCEMENT] HTA COUNCIL RELEASES ITS PRELIMINARY RECOMMENDATION ON THE FINANCING OF DAPAGLIFLOZIN FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS